


























![]()
Q1: 2026-05-06 Earnings Summary
EPS of -$0.11 misses by $0.06
|
Revenue of
$115.24M
(44.92% Y/Y)
beats by $6.13M
Core Scientific, Inc. (CORZ) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT
Company Participants
Jon Charbonneau - Vice President of Investor Relations
Adam Sullivan - CEO, President & Director
Matt Brown - Chief Operating Officer
Jim Nygaard - Executive VP & CFO
Conference Call Participants
Brett Knoblauch - Cantor Fitzgerald & Co., Research Division
John Todaro - Needham & Company, LLC, Research Division
Timothy Horan - Oppenheimer & Co. Inc., Research Division
Michael Donovan - Compass Point Research & Trading, LLC, Research Division
Joseph Vafi - Canaccord Genuity Corp., Research Division
Paul Golding - Macquarie Research
George Sutton - Craig-Hallum Capital Group LLC, Research Division
Jon Hickman - Ladenburg Thalmann & Co. Inc., Research Division
Henry Hearle - B. Riley Securities, Inc., Research Division
Stephen Glagola - Keefe, Bruyette, & Woods, Inc., Research Division
Presentation
Operator
Greetings. Welcome to the Core Scientific Fiscal First Quarter 2026 Earnings Conference Call. [Operator Instructions]. Please note, this conference is being recorded. I will now turn the conference over to your host, Jonathan Charbonneau, SVP, Investor Relations. Please go ahead, sir.
Jon Charbonneau
Vice President of Investor Relations
Great. Thank you. Good afternoon, and welcome to Core Scientific's First Quarter 2026 Earnings Call. Before we begin, I need to remind you that statements made on this call other than historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on our current expectations. Words such as anticipates, estimates, expects, intends and believes and similar words and expressions are intended to identify forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ substantially. For further information on these risks and uncertainties, we encourage you to review the risk factors discussed in the company's reports on Form 10-Q and 8-K filed today with the SEC and the press release and slide presentation contained therein.
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。